EUVIMEDExplore EUVIMED
Crossref

Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort

Yuyuan Wang, Jianhan Huang, Xian Yin, Qinghua Xu, Yifeng Sun, Yu Yao, Ji Xiong

Acta Neurochirurgica · 2024

DOI: 10.1007/s00701-024-05922-5 ↗

At a glance

Journal article in Acta Neurochirurgica, 2024. Written by Yuyuan Wang and 6 co-authors. Institution: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China. Major MEDLINE topics: Medulloblastoma, Brain Neoplasms, Cerebellar Neoplasms. Cited 2 times so far (Crossref); 30 references. Funded by: Science and Technology Commission of Shanghai Municipality.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

PURPOSE: Medulloblastoma is the most common childhood malignant brain tumor and is a leading cause of cancer-related death in children. Recent transcriptional studies have shown that medulloblastomas comprise at least four molecular subgroups, each with distinct demographics, genetics, and clinical outcomes. Medulloblastoma subtyping has become critical for subgroup-specific therapies. The use of gene expression assays to determine the molecular subgroup of clinical specimens is a long-awaited application of molecular biology for this pediatric cancer. METHODS: In the current study, we established a medulloblastoma transcriptome database of 460 samples retrieved from three published datasets (GSE21140, GSE37382, and GSE37418). With this database, we identified a 23-gene signature that is significantly associated with the medulloblastoma subgroups and achieved a classification accuracy of 95.2%. RESULTS: The 23-gene signature was further validated in a long-term cohort of 142 Chinese medulloblastoma patients. The 23-gene signature classified 21 patients as WNT (15%), 41 as SHH (29%), 16 as Group 3 (11%), and 64 as Group 4 (45%). For patients of WNT, SHH, Group 3, and Group 4, 5-year overall-survival rate reached 80%, 62%, 27%, and 47%, respectively (p < 0.0001), meanwhile 5-year progression-free survival reached 80%, 52%, 27%, and 45%, respectively (p < 0.0001). Besides, SHH/TP53-mutant tumors were associated with worse prognosis compared with SHH/TP53 wild-type tumors and other subgroups. We demonstrated that subgroup assignments by the 23-gene signature and Northcott's NanoString assay were highly comparable with a concordance rate of 96.4%. CONCLUSIONS: In conclusion, we present a novel gene signature that is capable of accurately and reliably assigning FFPE medulloblastoma samples to their molecular subgroup, which may serve as an auxiliary tool for medulloblastoma subtyping in the clinic. Future incorporation of this gene signature into prospective clinical trials is warranted to further evaluate its clinical.

Subjects

MeSH terms (MEDLINE)

MedulloblastomaBrain NeoplasmsCerebellar NeoplasmsHumansChildTranscriptomeProspective StudiesChina

Author keywords

23-gene signatureGene expression signatureMedulloblastomaMolecular subgroupReal-time qPCR assayTranscriptome database

Authors and institutions

  • Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China.
  • Neurosurgical Institute of Fudan University, Shanghai, 200040, China.
  • Shanghai Clinical Medical Center of Neurosurgery, Shanghai, 200040, China.
  • Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, 200040, China.
  • Canhelp Genomics Research Center, Canhelp Genomics Co., Ltd, Hangzhou, 31100, Zhejiang Province, China.
  • Institute of Machine Learning and Systems Biology, College of Electronics and Information Engineering, Tongji University, Shanghai, 200092, China.

Funding

  • Science and Technology Commission of Shanghai Municipality

Cite

APA

Wang, Y., Huang, J., Yin, X., Xu, Q., Sun, Y., Yao, Y., & Xiong, J. (2024). Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort. Acta Neurochirurgica. https://doi.org/10.1007/s00701-024-05922-5

Vancouver

Wang Y, Huang J, Yin X, Xu Q, Sun Y, Yao Y, et al. Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort. Acta Neurochirurgica. 2024. doi:10.1007/s00701-024-05922-5

BibTeX
@article{Wang2024,
  author = {Wang, Yuyuan and Huang, Jianhan and Yin, Xian and Xu, Qinghua and Sun, Yifeng and Yao, Yu and Xiong, Ji},
  title = {Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort},
  journal = {Acta Neurochirurgica},
  year = {2024},
  doi = {10.1007/s00701-024-05922-5}
}
Start for free →